Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.5270
+0.0690 (15.07%)
At close: Oct 9, 2026, 4:00 PM EDT
0.5042
-0.0228 (-4.33%)
After-hours: Oct 9, 2026, 4:59 PM EDT
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $10.25 million as of October 9, 2026. It is the 42,301st most valuable company in the world and the 5,722nd biggest in the United States. Its market cap has increased by 40.46% in one year.
Market Cap
10.25M
Enterprise Value
9.77M
1-Year Change
40.46%
Global Rank
Country Rank
#5,722 United States
Category
ChartMarket Cap Chart
Since December 1, 2017, Ensysce Biosciences's market cap has decreased from $249.00M to $10.25M, a decrease of -95.88%. That is a compound annual growth rate of -30.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 10.25M | 210.72% |
| Dec 31, 2025 | 3.30M | -68.87% |
| Dec 31, 2024 | 10.60M | 221.21% |
| Dec 29, 2023 | 3.30M | -40.00% |
| Dec 30, 2022 | 5.50M | -95.18% |
| Dec 31, 2021 | 114.00M | 46.34% |
| Dec 31, 2020 | 77.90M | -70.10% |
| Dec 31, 2019 | 260.50M | 6.11% |
| Dec 31, 2018 | 245.50M | -0.89% |
| Dec 29, 2017 | 247.70M | -0.52% |
| Dec 1, 2017 | 249.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adial Pharmaceuticals | 10.58M |
| Vistagen Therapeutics | 10.56M |
| CytoMed Therapeutics | 10.52M |
| Chemomab Therapeutics | 10.36M |
| BioVie | 10.31M |
| Theriva Biologics | 10.19M |
| Lisata Therapeutics | 10.18M |
| Purple Biotech | 10.17M |